Cargando…

MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer

BACKGROUND: Epigenetic silencing of retinoic acid (RA) signaling-related genes have been linked with the pathogenesis and clinical outcome in oral squamous cell carcinoma (OSCC) carcinogenesis. However, the precise mechanisms underlying the abnormal silencing of RA signaling-related genes in OSCC ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiah, Shine-Gwo, Hsiao, Jenn-Ren, Chang, Hsiao-Ju, Hsu, Yuan-Ming, Wu, Guan-Hsun, Peng, Hsuan-Yu, Chou, Sung-Tau, Kuo, Ching-Chuan, Chang, Jang-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114797/
https://www.ncbi.nlm.nih.gov/pubmed/32238162
http://dx.doi.org/10.1186/s12929-020-00644-z
_version_ 1783513963968856064
author Shiah, Shine-Gwo
Hsiao, Jenn-Ren
Chang, Hsiao-Ju
Hsu, Yuan-Ming
Wu, Guan-Hsun
Peng, Hsuan-Yu
Chou, Sung-Tau
Kuo, Ching-Chuan
Chang, Jang-Yang
author_facet Shiah, Shine-Gwo
Hsiao, Jenn-Ren
Chang, Hsiao-Ju
Hsu, Yuan-Ming
Wu, Guan-Hsun
Peng, Hsuan-Yu
Chou, Sung-Tau
Kuo, Ching-Chuan
Chang, Jang-Yang
author_sort Shiah, Shine-Gwo
collection PubMed
description BACKGROUND: Epigenetic silencing of retinoic acid (RA) signaling-related genes have been linked with the pathogenesis and clinical outcome in oral squamous cell carcinoma (OSCC) carcinogenesis. However, the precise mechanisms underlying the abnormal silencing of RA signaling-related genes in OSCC have not been well investigated. METHODS: Using combined analysis of genome-wide gene expression and methylation profile from 40 matched normal-tumor pairs of OSCC specimens, we found a set of retinoid signaling related genes are frequently hypermethylated and downregulated in OSCC patient samples, including alcohol dehydrogenase, iron containing 1 (ADHFE1) and aldehyde dehydrogenase 1 family, member A2 (ALDH1A2), which are the important rate-limiting enzymes in synthesis of RA. The expression of ADHFE1 and ALDH1A2 in OSCC patients was determine by quantitative real-time PCR (qRT-PCR) and immunohistochemistry. The binding sites of miR-30a and miR-379 with DNA methyltransferase 3B (DNMT3B) were predicted using a series of bioinformatic tools, and validated using dual luciferase assay and Western blot analyses. The functions of miR-30a, miR-379, and DNMT3B were accessed by growth and colony formation analyses using gain- and loss-of-function approaches. Chromatin immunoprecipitation (ChIP) was performed to explore the molecular mechanisms by arecoline and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) treatment. RESULTS: We demonstrated that deregulated miR-30a and miR-379 could represent a mechanism for the silencing of ADHFE1 and ALDH1A2 in OSCC through targeting DNMT3B. Ectopic expression of miR-30a and miR-379 could induce re-expression of methylation-silenced ADHFE1 and ALDH1A2, and lead to growth inhibition in oral cancer cells. Furthermore, the dysregulation of the miRNAs and DNMT-3B may result from exposure to tobacco smoking and betel quid chewing. CONCLUSIONS: Our results demonstrate that tobacco smoking and betel quid chewing could repress miR-30a and miR-379, which upregulate the DNMT3B expression, in turn, lead to the hypermethylation of ADHFE1 and ALDH1A genes, consequently, promote the oncogenic activity. These findings highlight the potential use of retinoids in combination with epigenetic modifiers for the prevention or treatment of oral cancer.
format Online
Article
Text
id pubmed-7114797
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71147972020-04-07 MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer Shiah, Shine-Gwo Hsiao, Jenn-Ren Chang, Hsiao-Ju Hsu, Yuan-Ming Wu, Guan-Hsun Peng, Hsuan-Yu Chou, Sung-Tau Kuo, Ching-Chuan Chang, Jang-Yang J Biomed Sci Research BACKGROUND: Epigenetic silencing of retinoic acid (RA) signaling-related genes have been linked with the pathogenesis and clinical outcome in oral squamous cell carcinoma (OSCC) carcinogenesis. However, the precise mechanisms underlying the abnormal silencing of RA signaling-related genes in OSCC have not been well investigated. METHODS: Using combined analysis of genome-wide gene expression and methylation profile from 40 matched normal-tumor pairs of OSCC specimens, we found a set of retinoid signaling related genes are frequently hypermethylated and downregulated in OSCC patient samples, including alcohol dehydrogenase, iron containing 1 (ADHFE1) and aldehyde dehydrogenase 1 family, member A2 (ALDH1A2), which are the important rate-limiting enzymes in synthesis of RA. The expression of ADHFE1 and ALDH1A2 in OSCC patients was determine by quantitative real-time PCR (qRT-PCR) and immunohistochemistry. The binding sites of miR-30a and miR-379 with DNA methyltransferase 3B (DNMT3B) were predicted using a series of bioinformatic tools, and validated using dual luciferase assay and Western blot analyses. The functions of miR-30a, miR-379, and DNMT3B were accessed by growth and colony formation analyses using gain- and loss-of-function approaches. Chromatin immunoprecipitation (ChIP) was performed to explore the molecular mechanisms by arecoline and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) treatment. RESULTS: We demonstrated that deregulated miR-30a and miR-379 could represent a mechanism for the silencing of ADHFE1 and ALDH1A2 in OSCC through targeting DNMT3B. Ectopic expression of miR-30a and miR-379 could induce re-expression of methylation-silenced ADHFE1 and ALDH1A2, and lead to growth inhibition in oral cancer cells. Furthermore, the dysregulation of the miRNAs and DNMT-3B may result from exposure to tobacco smoking and betel quid chewing. CONCLUSIONS: Our results demonstrate that tobacco smoking and betel quid chewing could repress miR-30a and miR-379, which upregulate the DNMT3B expression, in turn, lead to the hypermethylation of ADHFE1 and ALDH1A genes, consequently, promote the oncogenic activity. These findings highlight the potential use of retinoids in combination with epigenetic modifiers for the prevention or treatment of oral cancer. BioMed Central 2020-04-02 /pmc/articles/PMC7114797/ /pubmed/32238162 http://dx.doi.org/10.1186/s12929-020-00644-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shiah, Shine-Gwo
Hsiao, Jenn-Ren
Chang, Hsiao-Ju
Hsu, Yuan-Ming
Wu, Guan-Hsun
Peng, Hsuan-Yu
Chou, Sung-Tau
Kuo, Ching-Chuan
Chang, Jang-Yang
MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer
title MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer
title_full MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer
title_fullStr MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer
title_full_unstemmed MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer
title_short MiR-30a and miR-379 modulate retinoic acid pathway by targeting DNA methyltransferase 3B in oral cancer
title_sort mir-30a and mir-379 modulate retinoic acid pathway by targeting dna methyltransferase 3b in oral cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114797/
https://www.ncbi.nlm.nih.gov/pubmed/32238162
http://dx.doi.org/10.1186/s12929-020-00644-z
work_keys_str_mv AT shiahshinegwo mir30aandmir379modulateretinoicacidpathwaybytargetingdnamethyltransferase3binoralcancer
AT hsiaojennren mir30aandmir379modulateretinoicacidpathwaybytargetingdnamethyltransferase3binoralcancer
AT changhsiaoju mir30aandmir379modulateretinoicacidpathwaybytargetingdnamethyltransferase3binoralcancer
AT hsuyuanming mir30aandmir379modulateretinoicacidpathwaybytargetingdnamethyltransferase3binoralcancer
AT wuguanhsun mir30aandmir379modulateretinoicacidpathwaybytargetingdnamethyltransferase3binoralcancer
AT penghsuanyu mir30aandmir379modulateretinoicacidpathwaybytargetingdnamethyltransferase3binoralcancer
AT chousungtau mir30aandmir379modulateretinoicacidpathwaybytargetingdnamethyltransferase3binoralcancer
AT kuochingchuan mir30aandmir379modulateretinoicacidpathwaybytargetingdnamethyltransferase3binoralcancer
AT changjangyang mir30aandmir379modulateretinoicacidpathwaybytargetingdnamethyltransferase3binoralcancer